NCT05843253: An ongoing trial by Nationwide Children's Hospital
This trial is ongoing. It must report results 4 years, 5 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05843253 |
|---|---|
| Title | PhaseII Study of Ribociclib and Everolimus Following Radiotherapy in Pediatric and Young Adult Patients Newly Diagnosed with HGG Including DIPG, Which Harbor Alterations of the Cell Cycle And/or PI3K/mTOR Pathways |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 22, 2024 |
| Completion date | Aug. 28, 2028 |
| Required reporting date | Aug. 28, 2029, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |